FDA Approves First Gene Therapy for Aromatic L-amino Acid Decarboxylase (AADC) Deficiency: A Landmark in Rare Disease Treatment
IntroductionThe U.S. Food and Drug Administration (FDA) has recently approved a ground-breaking gene therapy for the treatment of Aromatic L-amino Acid Decarboxylase (AADC) deficiency, marking a significant advancement in the field of genetic disorders. This
Read More